SpringWorks Therapeutics Inc expected to post a loss of $1.26 a share - Earnings Preview

SpringWorks Therapeutics

31/07/2023 11:33

* SpringWorks Therapeutics Inc  SWTX.OQ   SWTX.O  is
expected
to show no change in quarterly revenue when it reports 
results on August 2 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for SpringWorks
Therapeutics
Inc is for a loss of $1.26 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for SpringWorks
Therapeutics Inc is $45​, above​ its last closing price
of $30.58. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -1.31       -1.25      -1.18     Beat    5.9
 Dec. 31 2023  -1.22       -1.22      -1.17     Beat    4.2
 Sep. 30 2022  -1.30       -1.32      -1.37     Missed  -3.8​
 Jun. 30 2022  -1.22       -1.20      -1.41     Missed  -17.2
 ​​Mar.        -1.07       -1.02      -1.26     Missed  -23.1
 31 2022                                                
 Dec. 31 2021  -0.88       -0.88      -1.15     Missed  -31​
 Sep. 30 2021  -0.80       -0.76      -0.84     Missed  -10.2
 Jun. 30 2021  -0.68       -0.67      -0.97     Missed  -44.3
 This summary was machine generated July 31 at 10:33 GMT.  All
figures in US dollars  unless otherwise stated